Concepedia

Reetta Riikonen

RR

Statistics

Publications

6

Citations

524

H-Index

6

Active since

2000

Affiliations

University of Turku(Current)

Orion Corporation (Finland)

University of Jyväskylä

Reetta Riikonen is an author at University of Turku specializing in pharmacology, prostate cancer, and oncology.

ORCID

Publications per year

2000–2022

6

Publications

6

Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies

Anu‐Maarit Moilanen, Reetta Riikonen, Riikka Oksala et al. · Scientific Reports · 2015 · 373 citations · Full text

, , +17

Integrin α2I Domain Recognizes Type I and Type IV Collagens by Different Mechanisms

Jarmo Käpylä, Johanna Ivaska, Reetta Riikonen et al. · Journal of Biological Chemistry · 2000 · 69 citations · Full text

, , +17

RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells

Heli Matilainen, Anna R. Mäkelä, Reetta Riikonen et al. · Journal of Biotechnology · 2006 · 24 citations

, , +12

First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis

Mari Karimaa, Reetta Riikonen, Henna Kettunen et al. · Molecular Cancer Therapeutics · 2022 · 24 citations · Full text

, , +17

Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1

Riikka Oksala, Anu Moilanen, Reetta Riikonen et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2018 · 22 citations · Full text

, , +17

1–5 of 6